Who owns BRIGHT MINDS BIOSCIENCES INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DRUG from SEC Form 13F filings across 110 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 110 institutions disclosed 9.0M shares of BRIGHT MINDS BIOSCIENCES INC. worth $447.8M — about 130.7% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
110
13F holders
$447.8M
value, 2026 filers
130.7%
of shares outstanding (9.0M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DRUG's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 1.3M | $67.0M | 0.0% | 19.6% | new |
| 2 | Cormorant Asset Management, LP | 800,000 | $39.9M | 2.7% | 11.6% | -11.1% |
| 3 | BlackRock, Inc. | 651,794 | $32.5M | 0.0% | 9.5% | -5.0% |
| 4 | Vestal Point Capital, LP | 545,000 | $27.2M | 0.7% | 7.9% | 0.0% |
| 5 | BRAIDWELL LP | 483,822 | $24.1M | 1.0% | 7% | 0.0% |
| 6 | Driehaus Capital Management LLC | 445,221 | $22.2M | 0.2% | 6.5% | +2.7% |
| 7 | Vivo Capital, LLC | 417,879 | $20.8M | 2.3% | 6.1% | -25.0% |
| 8 | Point72 Asset Management, L.P. | 372,481 | $18.6M | 0.0% | 5.4% | +13.8% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 324,800 | $16.2M | 0.0% | 4.7% | -3.0% |
| 10 | Balyasny Asset Management L.P. | 304,561 | $15.2M | 0.0% | 4.4% | -11.7% |
| 11 | RA CAPITAL MANAGEMENT, L.P. | 265,000 | $13.2M | 0.1% | 3.9% | 0.0% |
| 12 | DEERFIELD MANAGEMENT COMPANY, L.P. | 236,295 | $11.8M | 0.2% | 3.4% | -16.5% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 221,361 | $11.0M | 0.0% | 3.2% | +29.2% |
| 14 | MPM BIOIMPACT LLC | 195,669 | $9.7M | 0.7% | 2.8% | -3.2% |
| 15 | Parkman Healthcare Partners LLC | 148,227 | $7.4M | 0.7% | 2.2% | -27.7% |
| 16 | GOLDMAN SACHS GROUP INC | 135,089 | $6.7M | 0.0% | 2% | +1.0% |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | 130,013 | $6.5M | 0.1% | 1.9% | 0.0% |
| 18 | STATE STREET CORP | 122,150 | $6.1M | 0.0% | 1.8% | 0.0% |
| 19 | GREAT POINT PARTNERS LLC | 109,603 | $5.5M | 1.3% | 1.6% | 0.0% |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 104,059 | $5.2M | 0.0% | 1.5% | -0.1% |
| 21 | B Group, Inc. | 95,000 | $4.7M | 2.9% | 1.4% | +40.7% |
| 22 | ACUTA CAPITAL PARTNERS, LLC | 93,152 | $4.6M | 3.5% | 1.4% | +0.4% |
| 23 | Ikarian Capital, LLC | 88,951 | $4.4M | 0.4% | 1.3% | 0.0% |
| 24 | MILLENNIUM MANAGEMENT LLC | 88,640 | $4.4M | 0.0% | 1.3% | +32.8% |
| 25 | MORGAN STANLEY | 87,809 | $4.4M | 0.0% | 1.3% | +372.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.